Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.
暂无分享,去创建一个
F. Montemurro | M. Aglietta | M. Venturini | M. Donadio | S. Redana | S. Danese | G. Vietti-Ramus | M. Clavarezza | A. Durando | M. E. Jacomuzzi | G. Valabrega